109 related articles for article (PubMed ID: 20861293)
1. Simvastatin in the treatment of asthma: lack of steroid-sparing effect.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 Oct; 65(10):891-6. PubMed ID: 20861293
[TBL] [Abstract][Full Text] [Related]
2. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
Bateman ED; Bleecker ER; Lötvall J; Woodcock A; Forth R; Medley H; Davis AM; Jacques L; Haumann B; Busse WW
Respir Med; 2012 May; 106(5):642-50. PubMed ID: 22342538
[TBL] [Abstract][Full Text] [Related]
3. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
Rice-McDonald G; Bowler S; Staines G; Mitchell C
Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
[TBL] [Abstract][Full Text] [Related]
4. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
5. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
Fardon T; Haggart K; Lee DK; Lipworth BJ
Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
[TBL] [Abstract][Full Text] [Related]
6. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma.
Menzies D; Nair A; Meldrum KT; Fleming D; Barnes M; Lipworth BJ
J Allergy Clin Immunol; 2007 Feb; 119(2):328-35. PubMed ID: 17141851
[TBL] [Abstract][Full Text] [Related]
8. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
9. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
[TBL] [Abstract][Full Text] [Related]
10. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
Hoffmann HJ; Nielsen LP; Harving H; Heinig JH; Dahl R
Clin Respir J; 2008 Jul; 2(3):149-57. PubMed ID: 20298323
[TBL] [Abstract][Full Text] [Related]
11. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
Galant SP; Lawrence M; Meltzer EO; Tomasko M; Baker KA; Kellerman DJ
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
[TBL] [Abstract][Full Text] [Related]
12. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
Busse W; Raphael GD; Galant S; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
[TBL] [Abstract][Full Text] [Related]
13. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
[TBL] [Abstract][Full Text] [Related]
14. Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma.
Nimmagadda SR; Spahn JD; Nelson HS; Jenkins J; Szefler SJ; Leung DY
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):35-40. PubMed ID: 9690571
[TBL] [Abstract][Full Text] [Related]
15. Effects of steroid therapy on inflammatory cell subtypes in asthma.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
[TBL] [Abstract][Full Text] [Related]
16. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC
Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
[TBL] [Abstract][Full Text] [Related]
17. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
